|
|
Volumn 195, Issue 1, 2011, Pages
|
|
Is Australia ready to use glycated haemoglobin for the diagnosis of diabetes?
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
HEMOGLOBIN A1C;
BIOLOGICAL MARKER;
GLYCOSYLATED HEMOGLOBIN;
AUSTRALIA;
CLINICAL PRACTICE;
COST BENEFIT ANALYSIS;
DIABETES MELLITUS;
DIABETIC RETINOPATHY;
DIAGNOSTIC ACCURACY;
EDITORIAL;
ERYTHROCYTE LIFESPAN;
GLUCOSE BLOOD LEVEL;
GLYCEMIC CONTROL;
HEALTH CARE COST;
HEALTH CARE SYSTEM;
HEMOGLOBIN BLOOD LEVEL;
HUMAN;
MEDICARE;
ORAL GLUCOSE TOLERANCE TEST;
PHYSICIAN;
REIMBURSEMENT;
VALIDATION PROCESS;
ECONOMICS;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PREDICTIVE VALUE;
SENSITIVITY AND SPECIFICITY;
URINE;
AUSTRALIA;
BIOLOGICAL MARKERS;
DIABETES MELLITUS;
DIABETES MELLITUS, TYPE 2;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
PREDICTIVE VALUE OF TESTS;
SENSITIVITY AND SPECIFICITY;
|
|
EID: 79960086826
PISSN: 0025729X
EISSN: 13265377
Source Type: Journal
DOI: 10.5694/j.1326-5377.2011.tb03178.x Document Type: Editorial |
|
Times cited : (7)
|
|
References (5)
|
